Biotechnology Value Trading Fund OS LP, Director Other, Director, 10% Owner at Olema Pharmaceuticals, Inc. (OLMA), bought 400,000 shares at $4.03 ($1.6M) on 2022-06-10, disclosed to the SEC on 2022-06-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.03 | 41,417 | $167K | 10.4% |
| 2 | $4.03 | 41,417 | $167K | 10.4% |
| 3 | $4.03 | 158,583 | $639K | 39.6% |
| 4 | $4.03 | 158,583 | $639K | 39.6% |
| Total | $4.03 avg | 400,000 | $1.6M | 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2023-09-14 | $29.6M | — | Filing → |
| KYMR | BUY | 2022-01-26 | $20.6M | — | Filing → |